Vitiligo in a Patient Treated with Interferon Alpha-2a for Behçet’s Disease | Zendy

Esra Güney | Zendy; Gülünay Akçalı | Zendy; Betül İlkay Sezgin Akçay | Zendy; Cihan Ünlü | Zendy; Gürkan Erdoğan | Zendy; Tahir Kansu Bozkurt | Zendy; Hüseyin Bayramlar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Vitiligo in a Patient Treated with Interferon Alpha-2a for Behçet’s Disease

Author(s) -

Esra Güney,

Gülünay Akçalı,

Betül İlkay Sezgin Akçay,

Cihan Ünlü,

Gürkan Erdoğan,

Tahir Kansu Bozkurt,

Hüseyin Bayramlar

Publication year - 2012

Publication title -

case reports in medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.2

H-Index - 20

eISSN - 1687-9627

pISSN - 1687-9635

DOI - 10.1155/2012/387140

Subject(s) - vitiligo , medicine , behcet's disease , dermatology , disease , alpha interferon , behcet disease , alpha (finance) , interferon , immunology , surgery , construct validity , patient satisfaction

Behçet's disease (BD) and vitiligo are diseases of unknown etiology. Interferon (IFN) alpha therapy is commonly used in Behçet uveitis. Interferon treatment in various diseases have also been observed causing certain autoimmune diseases such as vitiligo because of its immunomodulatory activity. The association between IFN therapy and vitiligo has been reported in the literature. We report a 21-year-old man with BD in whom vitiligo occurred during IFN treatment. To the best of our knowledge, this is the first reported case of such an association.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research